Intelligence Β· Patent portfolio
United Therapeutics Europe Patents
Full USPTO pharma patent portfolio for United Therapeutics Europe β grant dates, expiration, and drug cross-links.
- Patents
- 3,720
- Expiring β€24m
- 234
Quick answer
United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β use filters for patent-cliff planning.
-
US 6475527
Use of chlorate ion or preparations thereof for reduction of food borne pathogens
expired -
US 6476201
Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
expired -
US 6475741
Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto
expired -
US 6472437
Active topical skin protectants
expired -
US 6472438
Active topical skin protectants containing S-330
expired -
US 6469049
Method of treating, preventing or inhibiting central nervous system injuries and diseases
expired -
US 6468524
AAV4 vector and uses thereof
expired -
US 6468983
RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
expired -
US 6458590
Methods and compositions for treatment of restenosis
expired -
US 6455509
Dengue nucleic acid vaccines that induce neutralizing antibodies
expired -
US 6451338
Liposomes containing particulate materials
expired -
US 6451763
Retinal pigmented epithelium derived neurotrophic factor and methods of use
expired -
US 6451309
Prophylactic and therapeutic monoclonal antibodies
expired -
US 6448245
Methods of and compounds for inhibiting calpains
expired -
US 6447796
Sustained release hydrophobic bioactive PLGA microspheres
expired -
US 6444445
Live vaccine against Brucellosis
expired -
US 6441156
Calcium channel compositions and methods of use thereof
expired -
US 6437005
Active topical skin protectants using polymer coated metal alloys
expired -
US 6432434
Treatment of and/or prophylaxis against brain and spinal cord injury
expired -
US 6432408
Swine hepatitis E virus and uses thereof
expired -
US 6433023
Compositions having anti-leishmanial activity
expired -
US 6428790
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
expired -
US 6429232
Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
expired -
US 6426075
Protease-activatable pseudomonas exotoxin A-like proproteins
expired -
US 6426198
Genes for Niemann-Pick type C disease
expired -
US 6426070
Methods for inactivating enveloped RNA virus particles and compositions for use therewith
expired -
US 6423308
Treatment of Kaposi's sarcoma with IL-12
expired -
US 6423835
Nucleotide deduced amino acid sequence, isolation and purification of heat-shock chlamydial proteins
expired -
US 6423513
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins
expired -
US 6423318
Hepatitis A virus vaccines
expired -
US 6423696
Inhibition of arylamine N-acetyl transferase
expired -
US 6423311
Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
expired -
US 6420434
Active topical skin protectants using polyoxometallates
expired -
US 6420531
Epithelial cell specific growth factor, keratinocyte growth factor (KGF)
expired -
US 6420336
Methods of using cyanovirins topically to inhibit viral infection
expired -
US 6417236
Active topical skin protectants using hybrid organic polysilsesquioxane materials
expired -
US 6416957
Method for modulating process mediated by farnesoid activated receptors
expired -
US 6417338
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
expired -
US 6414132
Method of eliminating inhibitory/instability regions of mRNA
expired -
US 6413523
Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use
expired -
US 6414039
Active topical skin protectants containing polyoxometalates and/or coinage metal complexes
expired -
US 6413544
Liposome complexes for increased systemic delivery
expired -
US 6410747
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
expired -
US 6410604
Active topical skin protectants containing OPAA enzymes and clecs
expired -
US 6410056
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
expired -
US 6410519
Scar reduction
expired -
US 6410012
Antimicrobial mediated bacterial DNA delivery
expired -
US 6410603
Active topical skin protectants using combinations of reactive nanoparticles and polyoxometalates or metal salts
expired
Frequently asked questions
How many patents does United Therapeutics Europe have?
3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do United Therapeutics Europe patents expire?
234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory